Bardoxolone Methyl (RTA402)
Product information
$69.30
Description
Description
Bardoxolone methyl (RTA402) is a potent Nrf2 transcription factor activator by targeting KEAP1 to prevent Nrf2 ubiquitination and degradation. It exhibits potent antioxidative and anti-inflammatory activities, currently under phase III clinical trials for multiple chronic kidney diseases. It also inhibits NFkappaB-mediated transcription.
Overview
Overview
Additional details
Downloads
Downloads
SKU
Manufacturer Part Number
UOM